✦ LIBER ✦

Response to Docetaxel/Carboplatin in Patients with Hormone-Refractory Prostate Cancer Not Responding to Taxane-Based Chemotherapy

✍ Scribed by Oh, William K.; George, Daniel J.; Tay, Miah-Hiang

Book ID: 119935369
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 852 KB
Volume: 4
Category: Article
ISSN: 1540-0352
DOI: 10.3816/cgc.2005.n.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to docetaxel/carboplatin-based

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Response to second-line chemotherapy in

Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes

✍ William K. Oh; Judith Manola; Vladana Babcic; Neesha Harnam; Philip W. Kantoff 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi

Docetaxel-based chemotherapy with zoledr

Docetaxel-based chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival

✍ Rishi Nayyar; Nitin Sharma; Narmada P Gupta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Editorial Comment to docetaxel-based com

Editorial Comment to docetaxel-based combination chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival

✍ Takeshi Yuasa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Weekly high-dose calcitriol and docetaxe

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel

✍ Roberto Petrioli; Alessandra Pascucci; Edoardo Francini; Stefania Marsili; Angel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB